Joseph K. Belanoff, Chief Executive Officer at CORCEPT THERAPEUTICS INC (CORT), sold 80,000 shares at $85.67 ($6.8M) on 2025-10-01, disclosed to the SEC on 2025-10-03.
Scheduled sale ($6.8M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $84.29 | 5,616 | $473K | 7.0% |
| 2 | $84.29 | 5,616 | $473K | 7.0% |
| 3 | $85.16 | 31,190 | $2.7M | 39.0% |
| 4 | $85.16 | 31,190 | $2.7M | 39.0% |
| 5 | $85.67 | 3,194 | $274K | 4.0% |
| 6 | $85.67 | 3,194 |
| $274K |
| 4.0% |
| Total | $85.08 avg | 80,000 | $6.8M | 100% |
| Filing → |
| CORT | SELL | 2026-03-27 | $2.6M | — | Filing → |
| CORT | SELL | 2025-12-03 | $3.2M | — | Filing → |
| CORT | SELL | 2025-11-05 | $4.9M | — | Filing → |